Joint Filer Information
Names: | Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Special Situations Fund, L.P. |
Address: | 780 Third Avenue, 37th Floor New York, NY 10017 |
Designated Filer: | James E. Flynn |
Issuer and Ticker Symbol: | Kiniksa Pharmaceuticals, Ltd. [KNSA] |
Date of Event Requiring Statement: | May 23, 2018 |
The undersigned, Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Special Situations Fund, L.P. are jointly filing the attached Initial Statement of Beneficial Ownership on Form 3 with James E. Flynn with respect to the beneficial ownership of securities ofKiniksa Pharmaceuticals, Ltd.
Signatures:
DEERFIELD MGMT, L.P.
By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD SPECIAL SITUATIONS FUND, L.P.
By: Deerfield Mgmt, L.P., General Partner
By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD MANAGEMENT COMPANY, L.P.
By: Flynn Management LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |